Significant Contract Modifications ($10M+) — October 31, 2026

Medline received an $88,992,131 firm-fixed-price delivery order from the VA (SAC Frederick) for September 2026 medical-surgical prime vendor expenditures under full and open competition with no set-aside.

The performance period runs only 2026-09-01 to 2026-09-30 with $0 outlayed to date and base-plus-options equal to the base value, so the $88.99M does not represent a multi-year commitment or option-driven revenue.

The Medline award shows an award date of 2026-10-28 against a start date of 2026-09-01 and $0 outlayed to date, creating ambiguity about whether this is a retroactive spend report or an active obligation.

The award was full and open competition with no set-aside, so the Medline VA prime vendor position is contestable and not protected by a sole-source or set-aside moat.

If the $88.99M September 2026 Medline VA prime vendor spend recurs monthly, it implies a ~$1.07B annualized run-rate, though this pattern is not confirmed by the single data point.

The sole contract this period is an $88.99M VA medical-surgical prime vendor expenditure report to Medline, evidencing meaningful but single-month civilian medical-supply spending with trend direction not determinable from one data point.

{"entity" => "Medline Industries, LP", "reason" => "$88,992,131 VA delivery order is a one-month performance period with $0 outlayed to date; recurrence is needed to validate any annualized run-rate.", "trigger" => "Issuance of subsequent monthly VA prime vendor delivery orders to Medline"}